Cargando…

Comparison of efficacy between incretin-based therapies for type 2 diabetes mellitus

Type 2 diabetes mellitus is widely prevalent and is often coexistent with obesity. Many of the available treatment options have side effects such as weight gain which often affect patient's willingness to continue the treatment. Effective weight loss, lack of significant hypoglycaemia, and favo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nisal, Kaustubh, Kela, Ram, Khunti, Kamlesh, Davies, Melanie J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3599222/ https://www.ncbi.nlm.nih.gov/pubmed/23198896 http://dx.doi.org/10.1186/1741-7015-10-152

Ejemplares similares

Renoprotective Effects of Incretin-Based Therapy in Diabetes Mellitus
por: Yaribeygi, Habib, et al.
Publicado: (2021)

Type 2 diabetes mellitus and the cardiometabolic syndrome: impact of incretin-based therapies
por: Schwartz, Stanley, et al.
Publicado: (2010)

Potentials of incretin‐based therapies in dementia and stroke in type 2 diabetes mellitus
por: Groeneveld, Onno N, et al.
Publicado: (2015)

The treatment of type 2 diabetes in the presence of renal impairment: what we should know about newer therapies
por: Davies, Melanie, et al.
Publicado: (2016)

Fruit and vegetable intake and incidence of type 2 diabetes mellitus: systematic review and meta-analysis
por: Carter, Patrice, et al.
Publicado: (2010)

The efficacy of incretin therapy in patients with type 2 diabetes undergoing hemodialysis
por: Terawaki, Yuichi, et al.
Publicado: (2013)

Differentiating among incretin-based therapies in the management of patients with type 2 diabetes mellitus
por: Cobble, Michael
Publicado: (2012)

Dietary Recommendations for the Prevention of Type 2 diabetes: What Are They Based on?
por: Carter, Patrice, et al.
Publicado: (2012)

Incretin - based therapy in diabetes mellitus: present scenario and expanding horizons
por: Kohli, Suresh Chandra
Publicado: (2016)

Association of smoking and cardiometabolic parameters with albuminuria in people with type 2 diabetes mellitus: a systematic review and meta-analysis
por: Kar, Debasish, et al.
Publicado: (2019)

Incretin-based therapy: a powerful and promising weapon in the treatment of type 2 diabetes mellitus
por: Koliaki, Chrysi, et al.
Publicado: (2011)

Comparison of incretin immunoassays with or without plasma extraction: Incretin secretion in Japanese patients with type 2 diabetes
por: Yabe, Daisuke, et al.
Publicado: (2011)

A Review of Exenatide: Optimizing Glycemic Control and Associated Cardiovascular Risk Factors in Type 2 Diabetes
por: Htike, Zin Z., et al.
Publicado: (2012)

The Prevalence of Depression in White-European and South-Asian People with Impaired Glucose Regulation and Screen-Detected Type 2 Diabetes Mellitus
por: Aujla, Navneet, et al.
Publicado: (2009)

Incretin hormones and type 2 diabetes
por: Nauck, Michael A., et al.
Publicado: (2023)

Incretins and microvascular complications of diabetes: neuropathy, nephropathy, retinopathy and microangiopathy
por: Goldney, Jonathan, et al.
Publicado: (2023)

The evolving place of incretin-based therapies in type 2 diabetes
por: Gallwitz, Baptist
Publicado: (2010)

Incretins in the Therapy of Diabetic Kidney Disease
por: Przezak, Agnieszka, et al.
Publicado: (2021)

Factors Related to Blood Intact Incretin Levels in Patients with Type 2 Diabetes Mellitus
por: Yoo, Soyeon, et al.
Publicado: (2019)

Cardiovascular Effect of Incretin-Based Therapy in Patients with Type 2 Diabetes Mellitus: Systematic Review and Meta-Analysis
por: Kim, Je-Yon, et al.
Publicado: (2016)

Incretins as a Potential Treatment Option for Gestational Diabetes Mellitus
por: Pilszyk, Aleksandra, et al.
Publicado: (2022)

Beyond Glycemic Control in Diabetes Mellitus: Effects of Incretin-Based Therapies on Bone Metabolism
por: Ceccarelli, Elena, et al.
Publicado: (2013)

Emerging role of insulin with incretin therapies for management of type 2 diabetes
por: Ahluwalia, Rupa, et al.
Publicado: (2011)

Role of incretin‐based therapy in hospitalized patients with type 2 diabetes
por: Gracia‐Ramos, Abraham Edgar
Publicado: (2019)

Correction: Cardiovascular Effect of Incretin-Based Therapy in Patients with Type 2 Diabetes Mellitus: Systematic Review and Meta-Analysis
por: Kim, Je-Yon, et al.
Publicado: (2018)

Medicinal Chemistry and Applications of Incretins and DPP-4 Inhibitors in the Treatment of Type 2 Diabetes Mellitus
por: Lotfy, Mohamed, et al.
Publicado: (2011)

Calculating the design effect for a cluster stepped-wedge trial with varying cluster size; a case study from a trial in type 2 diabetes
por: Ashra, Nuzhat, et al.
Publicado: (2015)

Engagement, Retention, and Progression to Type 2 Diabetes: A Retrospective Analysis of the Cluster-Randomised "Let's Prevent Diabetes" Trial
por: Gray, Laura J., et al.
Publicado: (2016)

Rationale and study design for a randomised controlled trial to reduce sedentary time in adults at risk of type 2 diabetes mellitus: project stand (Sedentary Time ANd diabetes)
por: Wilmot, Emma G, et al.
Publicado: (2011)

Incretin-based therapies
por: Stonehouse, Anthony H, et al.
Publicado: (2012)

Empagliflozin influences blood viscosity and wall shear stress in subjects with type 2 diabetes mellitus compared with incretin-based therapy
por: Irace, Concetta, et al.
Publicado: (2018)

Effects of incretin-based therapies on β-cell function in type 1 diabetes mellitus: a systematic review and meta-analysis
por: Wu, Yucheng, et al.
Publicado: (2021)

Health Economic Evaluation of Type 2 Diabetes Mellitus: A Clinical Practice Focused Review
por: Liebl, Andreas, et al.
Publicado: (2015)

Differences in Dietary Intake, Eating Occasion Timings and Eating Windows between Chronotypes in Adults Living with Type 2 Diabetes Mellitus
por: Katsarova, Stanislava S., et al.
Publicado: (2023)

Linagliptin Increases Incretin Levels, Lowers Glucagon, and Improves Glycemic Control in Type 2 Diabetes Mellitus
por: Rauch, Thomas, et al.
Publicado: (2012)

The catcher in the gut: Tirzepatide, a dual incretin analog for the treatment of type 2 diabetes mellitus and obesity
por: Lempesis, Ioannis G., et al.
Publicado: (2022)

Incretin-Based Therapies for the Treatment of Type 2 Diabetes: Evaluation of the Risks and Benefits
por: Drucker, Daniel J., et al.
Publicado: (2010)

Incretin-based therapies: new treatments for type 2 diabetes in the new millennium
por: Khoo, Joan, et al.
Publicado: (2009)

Incorporating Incretin-Based Therapies into Clinical Practice for Patients with Type 2 Diabetes
por: Tibaldi, Joseph M.
Publicado: (2014)

Combining Incretin-Based Therapies With Insulin: Realizing the potential in type 2 diabetes
por: Vora, Jiten
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_l1nj7f51rombo14n8ng10ela8i